Chung et al., 2021
Featured review: Cellular and pathological heterogeneity of primary tauopathies
Dah-eun Chloe Chung, ... & Dennis W. Dickson
Bai et al. 2021
Castelli et al. 2021
Featured research: SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis
Lydia M. Castelli, ... & Guillaume M. Hautbergue
Barth et al., 2021
Barrera et al. 2021
Featured Research: Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer’s disease brains
Julio Barrera, ... & Ornit Chiba-Falek
Farmer et al. 2021
Featured Research: APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis
Brandon C. Farmer, ... & Lance A. Johnson
Articles
-
-
METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
-
The TGFβ/Notch axis facilitates Müller cell-to-epithelial transition to ultimately form a chronic glial scar
-
Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques
-
Measuring the cognitive costs of the COVID-19 pandemic
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
The neuropathological diagnosis of Alzheimer’s disease
-
α-Synuclein and neuronal cell death
-
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
-
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Editor highlights
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
-
-
Aduhelm Administration Remains a Trickle, ARIA a Concern
20 October 2021
-
Lecanemab Follows Aduhelm’s Path to Accelerated Approval
20 October 2021
Contact the Managing Editorial Team
Hongmei Li - Hongmei.Li@MolecularNeurodegeneration.org
Lucy Job - Lucy.Job@MolecularNeurodegeneration.org
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Follow
Annual Journal Metrics
-
Speed
58 days to first decision for reviewed manuscripts only
31 days to first decision for all manuscripts
153 days from submission to acceptance
28 days from acceptance to publication
Citation Impact
14.195 - 2-year Impact Factor
11.684 - 5-year Impact Factor
2.172 - Source Normalized Impact per Paper (SNIP)
5.565 - SCImago Journal Rank (SJR)
Usage
770,533 downloads
723 Altmetric mentions